| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $319K | +5.3% |
| SG&A Expense | $458K | +4.8% |
| Operating Income | -$777K | -5.0% |
| Interest Expense | $13K | +533.3% |
| Net Income | -$842K | -8.2% |
| EPS (Basic) | -$0.09 | — |
| EPS (Diluted) | -$0.09 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $175K | +2087.5% |
| Accounts Receivable | $20K | -53.5% |
| Current Assets | $259K | +407.8% |
| Total Assets | $332K | +2.8% |
| Current Liabilities | $913K | +162.4% |
| Total Liabilities | $945K | +138.0% |
| Stockholders' Equity | -$613K | -728.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$610K | +1.1% |
| Investing Cash Flow | $3K | +113.0% |
| Financing Cash Flow | $777K | +25.1% |